| Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody CG Rappazzo, LV Tse, CI Kaku, D Wrapp, M Sakharkar, D Huang, ... Science 371 (6531), 823-829, 2021 | 301 | 2021 |
| Prolonged evolution of the human B cell response to SARS-CoV-2 infection M Sakharkar, CG Rappazzo, WF Wieland-Alter, CL Hsieh, D Wrapp, ... Science immunology 6 (56), eabg6916, 2021 | 181 | 2021 |
| Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice CG Rappazzo, HC Watkins, CM Guarino, A Chau, JL Lopez, MP DeLisa, ... Vaccine 34 (10), 1252-1258, 2016 | 125 | 2016 |
| Safe recombinant outer membrane vesicles that display M2e elicit heterologous influenza protection HC Watkins, CG Rappazzo, JS Higgins, X Sun, N Brock, A Chau, A Misra, ... Molecular Therapy 25 (4), 989-1002, 2017 | 95 | 2017 |
| IL-33 signaling alters regulatory T cell diversity in support of tumor development A Li, RH Herbst, D Canner, JM Schenkel, OC Smith, JY Kim, M Hillman, ... Cell reports 29 (10), 2998-3008. e8, 2019 | 72 | 2019 |
| Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction CG Rappazzo, BD Huisman, ME Birnbaum Nature communications 11 (1), 4414, 2020 | 46 | 2020 |
| A combination of receptor-binding domain and N-terminal domain neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants D Haslwanter, ME Dieterle, AZ Wec, CM O’brien, M Sakharkar, C Florez, ... Mbio 12 (5), 10.1128/mbio. 02473-21, 2021 | 43 | 2021 |
| Vaccination reshapes the virus-specific T cell repertoire in unexposed adults YG Pan, B Aiamkitsumrit, L Bartolo, Y Wang, C Lavery, A Marc, PV Holec, ... Immunity 54 (6), 1245-1256. e5, 2021 | 24 | 2021 |
| Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein CG Rappazzo, CL Hsieh, SA Rush, ES Esterman, T Delgado, ... Immunity 55 (9), 1710-1724. e8, 2022 | 14 | 2022 |
| Defining and studying B cell receptor and TCR interactions CG Rappazzo, ML Fernández-Quintero, A Mayer, NC Wu, V Greiff, ... The Journal of Immunology 211 (3), 311-322, 2023 | 12 | 2023 |
| Identification of highly cross-reactive mimotopes for a public T cell response in murine melanoma BE Grace, CM Backlund, DM Morgan, BH Kang, NK Singh, BD Huisman, ... Frontiers in Immunology 13, 886683, 2022 | 9 | 2022 |
| Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody E Mittler, A Serris, ES Esterman, C Florez, LC Polanco, CM O’Brien, ... Science translational medicine 15 (700), eadg1855, 2023 | 8 | 2023 |
| Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages M Chernyshev, M Sakharkar, RI Connor, HL Dugan, DJ Sheward, ... Nature Communications 14 (1), 2249, 2023 | 6 | 2023 |
| Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2 RI Connor, M Sakharkar, CG Rappazzo, CI Kaku, NC Curtis, S Shin, ... Pathogens and Immunity 9 (2), 1, 2024 | 1 | 2024 |
| Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report J Cable, S Balachandran, LP Daley‐Bauer, A Rustagi, F Antony, JJ Frere, ... Annals of the New York Academy of Sciences 1521 (1), 32-45, 2023 | | 2023 |
| Compounds specific to coronavirus S protein and uses thereof L Walker, L Deveau, J Belk, A Wec, CG Rappazzo US Patent 11,414,479, 2022 | | 2022 |
| Compounds specific to coronavirus s protein and uses thereof L Walker, L Deveau, J Belk, A Wec, CG Rappazzo US Patent App. 17/539,635, 2022 | | 2022 |
| Determination of class II peptide-MHC repertoires and recognition via large yeast-displayed libraries CG Rappazzo Massachusetts Institute of Technology, 2020 | | 2020 |
| An Unbiased Determination of pMHC Repertoires for Improved Antigen Prediction CG Rappazzo, M Birnbaum The Journal of Immunology 200 (1_Supplement), 99.30-99.30, 2018 | | 2018 |
| Tuning up T-cell receptors CG Rappazzo, ME Birnbaum Nature Biotechnology, 2017 | | 2017 |
Michael BirnbaumMIT在 mit.edu 的电子邮件经过验证
Michael BirnbaumMIT在 mit.edu 的电子邮件经过验证
Hannah WatkinsAdimab在 adimab.com 的电子邮件经过验证